THE INVESTMENT
Building the next generation of medical intelligence
Nordic Care has progressed from concept to a functioning real-time medical intelligence prototype. The next phase is about advancing that technology toward a clinically validated, regulatory-ready and scalable medical product.
Investment will accelerate the development required to move from working technology to controlled real-world deployment — while building the clinical, regulatory and technical foundations for international scale.
THE NEXT PHASE
Capital to de-risk the path from working technology to validated medical product
PRODUCT & ENGINEERING
Advance medical evidence integration, clinical reasoning, longitudinal intelligence, multimodal consultation and the core platform.
CLINICAL & REGULATORY
Formalise intended purpose and regulatory classification, establish the clinical evidence strategy and progress toward the requirements for regulated deployment.
SECURITY & DATA
Build the privacy, cybersecurity and health-data architecture required for a trusted medical platform.
VALIDATION & PILOT
Move from engineering validation into structured clinical evaluation and controlled pilot deployment.
CORE TEAM
Build the specialist medical, regulatory and technical capability required for the next stage.
The objective is not simply to build more features. It is to systematically remove the risks between a working prototype and a deployable medical product.
THE INVESTMENT PROPOSITION
One medical intelligence.
Multiple paths to scale
Nordic Care is being built around an intelligence platform rather than a single healthcare interaction.
The same underlying medical intelligence can support individuals and families, employers and organisations, healthcare environments and institutional partners — while continuity allows relevant health context to develop across interactions over time.
This creates the potential for Nordic Care to scale through multiple commercial relationships without requiring a different core intelligence for every market.
DIRECT ACCESS
A continuing relationship with individuals and families.
Direct access creates a route to market built around an ongoing relationship with ANNA, not simply an isolated healthcare interaction.
INSTITUTIONAL SCALE
One platform capable of serving larger populations.
Employers, healthcare organisations, insurers and institutional partners create potential routes to deployment across significantly larger populations.
PLATFORM VALUE
The intelligence remains at the centre.
Conversation, longitudinal health context, medical evidence, clinical reasoning and safety are designed as reusable intelligence layers — creating a foundation that can extend across interfaces, markets and distribution models.
The opportunity extends beyond individual consultations.
It is to build medical intelligence people and organisations can return to.
WHY NORDIC CARE
The foundations for a different kind of medical intelligence
WORKING TECHNOLOGY
The core real-time consultation technology already exists.
A DIFFERENT MODEL OF MEDICAL AI
Nordic Care is being built around consultation, context, continuity and safety — not isolated answers.
MULTIPLE ROUTES TO SCALE
One underlying intelligence can support direct consumer, healthcare and institutional relationships.
A DEFINED PATH FORWARD
The next development phase has clear technical, clinical, regulatory and validation objectives.